Gustavo Citera Selected Research

Gustavo Citera Research Topics

Disease

23	Rheumatoid Arthritis 03/2022 - 06/2004
6	Ankylosing Spondylitis 10/2022 - 10/2008
4	Infections 01/2021 - 01/2013
3	Axial Spondyloarthritis 10/2022 - 08/2014
3	Injection Site Reaction 09/2021 - 01/2013
3	Arthritis (Polyarthritis) 01/2021 - 01/2019
3	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2019 - 04/2008
3	Psoriatic Arthritis 12/2019 - 04/2008
3	Inflammation (Inflammations) 10/2017 - 08/2014
2	Rheumatic Diseases (Rheumatism) 01/2022 - 01/2012
2	Pain (Aches) 09/2021 - 06/2004
2	Tuberculosis (Tuberculoses) 01/2019 - 01/2014
2	Non-Radiographic Axial Spondyloarthritis 07/2018 - 07/2016
2	Sacroiliitis 08/2014 - 07/2013
1	Rheumatic Nodule 01/2022
1	Interstitial Lung Diseases (Interstitial Lung Disease) 12/2021
1	Drug-Related Side Effects and Adverse Reactions 09/2021
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2019
1	Opportunistic Infections (Opportunistic Infection) 01/2019
1	Back Pain (Backache) 07/2018
1	Disease Susceptibility (Diathesis) 05/2016
1	Spondylitis 08/2015
1	Low Back Pain (Lumbago) 07/2013
1	Balanitis 07/2013
1	Urethritis 07/2013
1	Anterior Uveitis 07/2013
1	Enthesopathy 07/2013
1	Osteolysis 01/2012
1	Eosinophilia 08/2008
1	Xerophthalmia 04/2008
1	Xerostomia 04/2008
1	Disease Progression 06/2004

Drug/Important Bio-Agent (IBA)

8	Etanercept (Enbrel)FDA Link 10/2022 - 08/2014
6	tofacitinibIBA 03/2022 - 06/2017
6	C-Reactive ProteinIBA 01/2022 - 06/2004
6	Biological ProductsIBA 01/2022 - 01/2013
4	ametantrone (HAQ)IBA 09/2021 - 06/2004
4	Adalimumab (Humira)FDA Link 01/2020 - 01/2013
3	Pharmaceutical PreparationsIBA 01/2022 - 08/2014
3	Abatacept (Orencia)FDA Link 01/2019 - 01/2013
3	HLA-B27 Antigen (HLA B27 Antigen)IBA 08/2015 - 07/2013
2	Janus Kinase InhibitorsIBA 12/2021 - 07/2017
2	Methotrexate (Mexate)FDA LinkGeneric 09/2021 - 01/2014
2	tocilizumab (atlizumab)FDA Link 06/2021 - 01/2019
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2021 - 08/2014
2	golimumab FDA Link 01/2020 - 12/2019
2	Infliximab (Remicade)FDA Link 01/2020 - 12/2019
2	Certolizumab Pegol FDA Link 01/2020 - 12/2019
2	HLA-DRB1 Chains (HLA DRB1)IBA 03/2019 - 06/2004
2	AntibodiesIBA 04/2008 - 06/2004
1	Rheumatoid FactorIBA 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	Biosimilar PharmaceuticalsIBA 09/2021
1	HDL LipoproteinsIBA 06/2021
1	oxidized low density lipoproteinIBA 06/2021
1	Tumor Necrosis Factor InhibitorsIBA 01/2020
1	Ustekinumab (CNTO 1275)FDA Link 12/2019
1	secukinumabIBA 12/2019
1	HLA Antigens (Human Leukocyte Antigens)IBA 03/2019
1	Tuberculin (PPD)IBA 01/2019
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 12/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2016
1	HLA-DR4 Antigen (HLA DR4 Antigen)IBA 08/2015
1	Antirheumatic Agents (DMARD)IBA 03/2013
1	amsonic acid (DAS)IBA 01/2011
1	Indicators and Reagents (Reagents)IBA 08/2008
1	EnzymesIBA 08/2008
1	ImmunosorbentsIBA 08/2008
1	Proteasome Endopeptidase Complex (Proteasome)IBA 04/2008
1	SS-A antibodiesIBA 04/2008
1	Anti-Citrullinated Protein AntibodiesIBA 06/2004
1	CytokinesIBA 06/2004

Therapy/Procedure

2	Therapeutics 01/2022 - 12/2017
1	Biological Therapy 01/2019
1	Hip Replacement Arthroplasty (Total Hip Replacement) 01/2012